Clinical Trial Update: A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial using functional MRI to evaluate the effects of extended-release naltrexone/bupropion therapy (Contrave) in overweight or obese adults; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CONTRAVE (bupropion/naltrexone)

Snippet

Sponsor: Orexigen Therapeutics, Inc | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2015-01-06